STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

CON insider filing: 60,000-share restricted stock award reported

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. A company officer filed a Form 4 showing acquisition of 60,000 shares of common stock as a restricted stock grant at $0 on 11/04/2025. Following this grant, the officer directly beneficially owns 120,000 shares. The award will vest in equal annual installments over four years.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gilbert Greg M.

(Last) (First) (Middle)
C/O CONCENTRA GROUP HOLDINGS PARENT, INC
5080 SPECTRUM DRIVE, SUITE 1200W

(Street)
ADDISON TX 75001

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Concentra Group Holdings Parent, Inc. [ CON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/04/2025 A(1) 60,000 A $0 120,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock which will vest in equal annual installments over four years.
Remarks:
Executive Vice President, Chief Reimbursement & Government Relations Officer
/s/ Timothy F. Ryan, Attorney-in-Fact 11/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Concentra (CON) disclose in this Form 4?

An officer acquired 60,000 shares of common stock as a restricted stock grant on 11/04/2025 at $0.

How many shares does the reporting person own after the transaction?

The filing shows 120,000 shares beneficially owned directly after the grant.

What is the vesting schedule for the restricted shares at CON?

The restricted stock will vest in equal annual installments over four years.

What transaction code is listed for the CON insider grant?

The transaction is coded A, indicating an acquisition (grant) of securities.

Was any price paid for the CON restricted stock grant?

The reported price is $0, consistent with a grant of restricted stock.

What is the reporting person’s role at Concentra (CON)?

The remarks list the officer as Executive Vice President, Chief Reimbursement & Government Relations Officer.
CONCENTRA GROUP HOLDINGS PAREN

NYSE:CON

CON Rankings

CON Latest News

CON Latest SEC Filings

CON Stock Data

2.64B
114.36M
9.95%
85.13%
1.91%
Medical Care Facilities
Services-specialty Outpatient Facilities, Nec
Link
United States
ADDISON